Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis A Gimotty

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
Breast Cancer Research : BCR|May 13, 2010
Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort studyPriya P Gor, H Irene Su, Robert J Gray, et al.
The Journal of Clinical Investigation|July 21, 2010
Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammationHongxia Z Imtiyaz, Emily P Williams, Michele M Hickey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Identification of high-risk patients among those diagnosed with thin cutaneous melanomasPhyllis A Gimotty, David E Elder, Douglas L Fraker, et al.
Annals of Surgical Oncology|January 4, 2020
Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III MelanomaYun Song, Richard J Straker, Xiaowei Xu, et al.
The American Journal of Surgical Pathology|January 26, 2011
High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanomaSook Jung Yun, Phyllis A Gimotty, Wei-Ting Hwang, et al.
Cancer|October 24, 2006
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanomaLaura L Kruper, Francis R Spitz, Brian J Czerniecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanomaXiaowei Xu, Lianjun Chen, DuPont Guerry, et al.
Annals of Surgical Oncology|November 2, 2019
Correction to: Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal MetastasisMinyoung Kwak, Yun Song, Phyllis A Gimotty, et al.
Annals of Surgical Oncology|August 9, 2019
Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal MetastasisMinyoung Kwak, Yun Song, Phyllis A Gimotty, et al.
Cell Cycle (Georgetown, Tex.)|May 12, 2011
Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomasDevraj Basu, Kathleen T Montone, Li-Ping Wang, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
Breast Cancer Research : BCR|May 13, 2010
Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort studyPriya P Gor, H Irene Su, Robert J Gray, et al.
The Journal of Clinical Investigation|July 21, 2010
Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammationHongxia Z Imtiyaz, Emily P Williams, Michele M Hickey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Identification of high-risk patients among those diagnosed with thin cutaneous melanomasPhyllis A Gimotty, David E Elder, Douglas L Fraker, et al.
Annals of Surgical Oncology|January 4, 2020
Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III MelanomaYun Song, Richard J Straker, Xiaowei Xu, et al.
The American Journal of Surgical Pathology|January 26, 2011
High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanomaSook Jung Yun, Phyllis A Gimotty, Wei-Ting Hwang, et al.
Cancer|October 24, 2006
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanomaLaura L Kruper, Francis R Spitz, Brian J Czerniecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanomaXiaowei Xu, Lianjun Chen, DuPont Guerry, et al.
Annals of Surgical Oncology|November 2, 2019
Correction to: Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal MetastasisMinyoung Kwak, Yun Song, Phyllis A Gimotty, et al.
Annals of Surgical Oncology|August 9, 2019
Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal MetastasisMinyoung Kwak, Yun Song, Phyllis A Gimotty, et al.
Cell Cycle (Georgetown, Tex.)|May 12, 2011
Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomasDevraj Basu, Kathleen T Montone, Li-Ping Wang, et al.
Pageof 15